PRGX Acquires Global EDGE’s Supplier Information Management (SIM) Business
Jan 11, 2016 12:30 pm UTC| Business
ATLANTA, Jan. 11, 2016 (GLOBE NEWSWIRE) -- PRGX Global, Inc. (Nasdaq:PRGX), the world’s leading provider of accounts payable recovery audit services, today announced the acquisition of Global EDGE’s Supplier Information...
Conatus Initiates Phase 2b ENCORE-NF Clinical Trial of Emricasan in Patients With NASH Fibrosis
Jan 11, 2016 12:30 pm UTC| Business
SAN DIEGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today announced the initiation of active patient recruitment in ENCORE-NF, a randomized, double-blind, placebo-controlled, Phase 2b...
TG Therapeutics, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference
Jan 11, 2016 12:30 pm UTC| Business
NEW YORK, Jan. 11, 2016 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Interim Chief Executive Officer, will present at the 34th Annual...
Jan 11, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) today outlined Vision 2020: Empowering Our Future, a strategic initiative designed to deepen and expand its pipeline over...
Amicus Therapeutics Provides Full-Year 2016 Strategic Outlook and Financial Guidance
Jan 11, 2016 12:30 pm UTC| Business
Migalastat for Fabry Disease Moving Toward CHMP Opinion in European Union Pompe Disease Clinical Study Initiated to Investigate Novel Enzyme Replacement Therapy Epidermolysis Bullosa (EB) Phase 3 Study Advances ...
Colliers International Acquires Groupe Immobilier (Montréal • Québec)
Jan 11, 2016 12:30 pm UTC| Business
TORONTO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Leading commercial real estate services firm Colliers International Group Inc. (“Colliers”) (NASDAQ:CIGI)(TSX:CIG) today announced the acquisition of Groupe Immobilier (Montréal...
Jan 11, 2016 12:05 pm UTC| Business
SAN RAMON, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address...